Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells 15,160 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 15,160 shares of Cardlytics stock in a transaction on Friday, January 24th. The shares were sold at an average price of $3.92, for a total value of $59,427.20. Following the completion of the transaction, the chief executive officer now owns 215,494 shares in the company, valued at $844,736.48. The trade was a 6.57 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Amit Gupta also recently made the following trade(s):

• On Friday, January 3rd, Amit Gupta sold 5,964 shares of Cardlytics stock. The shares were sold at an average price of $3.67, for a total value of $21,887.88.

Cardlytics Stock Up 1.3 %

Shares of NASDAQ CDLX traded up $0.05 during trading on Friday, reaching $3.88. 783,034 shares of the stock were exchanged, compared to its average volume of 1,083,136. Cardlytics, Inc. has a twelve month low of $2.76 and a twelve month high of $20.52. The company has a market capitalization of $197.18 million, a price-to-earnings ratio of -0.64 and a beta of 1.53. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40. The business’s 50-day moving average price is $3.66 and its 200 day moving average price is $4.39.

Cardlytics (NASDAQ:CDLX) last announced its earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.33) by $0.18. Cardlytics had a negative return on equity of 110.67% and a negative net margin of 93.55%. The company had revenue of $67.06 million during the quarter, compared to the consensus estimate of $57.77 million. During the same period last year, the firm earned ($0.26) earnings per share. The company’s revenue was down 15.1% on a year-over-year basis. As a group, equities analysts forecast that Cardlytics, Inc. will post -1.52 EPS for the current fiscal year.

Institutional Investors Weigh In On Cardlytics

Several hedge funds and other institutional investors have recently bought and sold shares of CDLX. Renaissance Technologies LLC raised its holdings in shares of Cardlytics by 711.9% during the second quarter. Renaissance Technologies LLC now owns 351,035 shares of the company’s stock worth $2,882,000 after purchasing an additional 307,800 shares during the period. XTX Topco Ltd bought a new stake in shares of Cardlytics during the second quarter valued at approximately $107,000. Marshall Wace LLP increased its position in Cardlytics by 6.8% in the 2nd quarter. Marshall Wace LLP now owns 814,281 shares of the company’s stock valued at $6,685,000 after acquiring an additional 52,081 shares during the period. SG Americas Securities LLC acquired a new position in Cardlytics during the 3rd quarter worth $45,000. Finally, Creative Planning increased its holdings in shares of Cardlytics by 35.4% during the third quarter. Creative Planning now owns 29,537 shares of the company’s stock valued at $95,000 after purchasing an additional 7,721 shares during the period. 68.10% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently commented on CDLX shares. Evercore ISI initiated coverage on shares of Cardlytics in a report on Friday, October 11th. They issued an “in-line” rating and a $4.00 price target on the stock. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research note on Friday, January 17th. Finally, Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Cardlytics currently has a consensus rating of “Hold” and a consensus target price of $6.92.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.